Clinical Trials Browser

Phase 4 × Leukemia, Lymphocytic, Chronic, B-Cell × ofatumumab × Clear all

NCT00802737 2014-05-14

Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)

Phase 4 Completed

29 enrolled 18 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell